Carboplatin/pemetrexedLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2025卷 / 1期

关键词：

D O I：

10.1007/s40278-024-66527-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：115 / 115

相关论文

共 50 条

[41] Gefitinib/pemetrexedLack of efficacy: case report
Reactions Weekly, 2022, 1930 (1) : 275 - 275
[42] Cisplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1945 (1) : 176 - 176
[43] Cisplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 254 - 254
[44] Aumolertinib/bevacizumab/pemetrexedLack of efficacy: case report
Reactions Weekly, 2022, 1908 (1) : 92 - 92
[45] Bevacizumab/nedaplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 94 - 94
[46] Bevacizumab/camrelizumab/pemetrexedLack of efficacy: case report
Reactions Weekly, 2022, 1916 (1) : 105 - 105
[47] Bevacizumab/lobaplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1981 (1) : 94 - 94
[48] Gefitinib/nedaplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1941 (1) : 202 - 202
[49] Cisplatin/pembrolizumab/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1964 (1) : 137 - 137
[50] Cisplatin/gemcitabine/pemetrexedLack of efficacy: case report
Reactions Weekly, 2021, 1857 (1) : 114 - 114

← 1 2 3 4 5 →